Press release
Navigating the Landscape of CINV Existing and Pipeline Drugs Market: Opportunities and Strategic Insights
CINV Existing and Pipeline Drugs Market
Request a Report Sample to Gain Comprehensive Insights @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=776
Market Overview:
Chemotherapy-induced nausea and vomiting (CINV) remains a significant concern for cancer patients undergoing chemotherapy. While several drugs are available to manage CINV, ongoing research and development activities aim to develop novel and more effective therapeutic solutions.
Factors such as the increasing incidence rate of various types of cancer, growing healthcare investments by governments, and the rising geriatric population suffering from cancer are driving the market growth.
Key Insights:
The market is witnessing a surge in R&D activities by pharmaceutical companies to develop advanced drugs for better CINV management. However, the lack of awareness among patients about effective treatments may hinder market growth.
SUSTOL (APF-530) and Rolapitant are among the key drugs dominating the market, offering improved efficacy and tolerability compared to existing options.
Opportunities and Challenges:
Opportunities lie in the increasing demand for CINV drugs due to the rising incidence of cancer and the development of novel therapies. However, challenges include the lack of awareness among patients and oncologists about effective treatment options.
Regional Outlook:
North America holds the largest market share, driven by high healthcare expenditure and early drug launches. Europe follows suit, with the launch of pipeline drugs projected to occur slightly later than in North America.
The Asia Pacific region is expected to witness significant growth, fueled by the penetration of western companies and the rise in cancer prevalence.
Buy this premium research report
https://www.transparencymarketresearch.com/checkout.php?rep_id=776<ype=S
Key Players and Developments:
Key players in the market include GlaxoSmithKline plc, Helsinn Holding S.A., Heron Therapeutics, Inc., Merck & Co., Inc., and Tesaro, Inc., among others.
Recent developments such as product launches and clinical studies indicate a robust pipeline of innovative therapies addressing CINV.
Recommendations:
Pharmaceutical companies should continue investing in R&D to develop novel drugs with improved efficacy and tolerability.
Efforts should be made to raise awareness among patients and oncologists about the availability of effective CINV treatments.
Expansion strategies should focus on regions with high unmet medical needs and untapped growth opportunities.
Explore More Trending Report by Transparency Market Research:
Cardiac Catheters & Guidewires Market
https://www.globenewswire.com/en/news-release/2023/03/13/2625808/0/en/Latest-Cardiac-Catheters-Guidewires-Market-Size-is-Expected-to-Reach-27-9-billion-by-2031-Rising-at-a-Market-Growth-of-7-9-CAGR-During-the-Forecast-Period.html
Severe Acute Respiratory Syndrome Treatment Market
https://www.globenewswire.com/en/news-release/2023/03/13/2625521/0/en/Severe-Acute-Respiratory-Syndrome-Treatment-Market-Value-to-Reach-US-8-6-Bn-by-2031-Data-Analysis-by-Experts-at-Transparency-Market-Research.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Navigating the Landscape of CINV Existing and Pipeline Drugs Market: Opportunities and Strategic Insights here
News-ID: 3394086 • Views: …
More Releases from Transparency Market Research
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion …
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronic…
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T …
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compound…
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil …
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036.
This growth trajectory reflects the transition of automobiles from mechanically driven products to…
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable …
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,…
More Releases for CINV
Rising Cancer Prevalence Spurs Growth In The Chemotherapy-Induced Nausea And Vom …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market encompassing chemotherapy-induced nausea and vomiting treatments has witnessed substantial expansion, projected to increase its valuation from $2.92 billion in 2024 to $3.13 billion in 2025, reflecting a compound annual growth…
CINV Treatment Market to Reach USD 3.9 Billion by 2034
Pune, India, November 11, 2025 - The global Chemotherapy-Induced Nausea and Vomiting (CINV) Treatment Market is projected to grow from USD 2.6 billion in 2024 to USD 3.9 billion by 2034, registering a CAGR of 4.1 %, according to Exactitude Consultancy. Rising cancer incidence, increasing chemotherapy adoption, and development of next-generation serotonin (5-HT3) and neurokinin-1 (NK1) receptor antagonists are driving global market expansion.
Download Full PDF Sample Copy of Market Report…
Emerging Trends Influencing The Growth Of The Chemotherapy-Induced Nausea and Vo …
The Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Expected to Be by 2034?
There has been a notable growth in the market size of chemotherapy-induced nausea and vomiting (CINV)…
Key Influencer in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market 202 …
How Are the key drivers contributing to the expansion of the chemotherapy-induced nausea and vomiting (cinv) market?
The escalating cases of cancer are expected to foster the expansion of the market for chemotherapy-induced nausea and vomiting (CINV). This rise is due to the uncontrolled development and spread of cancer cells in the body. As cancer prevalence increases, there's an increased drive to produce highly effective and specific anti-emetic treatments, which would…
CINV Existing and Pipeline Drugs Market: Rising Demand for CINV Drugs Owing to I …
CINV drugs are administered to patients suffering from vomiting and nausea that occurs as a side effect of chemotherapy. CINV can hinder the progress of patients undergoing chemotherapy, making it very crucial for oncologists to prescribe the right kind of CINV drugs to alleviate the discomfort. Delayed CINV and acute CINV are the two major subtypes of this condition. While the former occurs up to five days after treatment, the…
CINV Existing and Pipeline Drugs Market : Growing number of patients undergoing …
The growth of the global chemotherapy induced nausea and vomiting (CINV) market will be steered by the growing number of patients undergoing chemotherapy and a number of new drugs expected to be approved in the near future, says Transparency Market Research. In its report, titled “CINV Existing and Pipeline Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” the business intelligence firm says that…
